Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Annals of General Psychiatry
Published in: Annals of General Psychiatry 1/2015

Open Access 01-12-2015 | Primary research

A comparative study of anhedonia components between major depression and schizophrenia in Chinese populations

Authors: Yinghui Li, Xiaodong Mou, Wenhao Jiang, Zhong Yang, Xinhua Shen, Zhuma Jin, Zhiping Dai, Yuju Liu, Shengqin Mao, Jian Zhang, Yonggui Yuan

Published in: Annals of General Psychiatry | Issue 1/2015

Login to get access

Abstract

Background

Anhedonia is a prominent symptom of major depressive disorder (MDD) and schizophrenia. At present, it is believed that hedonic processing rather consists of the anticipatory and consummatory phase. The aim of this research is to explore the different anhedonia components in MDD and schizophrenia in Chinese populations.

Methods

A Chinese version of the Temporal Experience of Pleasure Scale (TEPS) was used to evaluate 176 MDD patients, 346 schizophrenia patients, and 268 healthy controls. Additionally, the 17-item Hamilton Depression Rating Scale (HAMD-17) was used for MDD patients, while the Positive and Negative Syndrome Scale (PANSS) was applied for schizophrenia.

Results

The scores of consummatory (TEPS-CON) and anticipatory pleasure (TEPS-ANT) in MDD and schizophrenia were both significantly lower than healthy controls (both P < 0.001). TEPS-CON and TEPS-ANT were negatively correlated with the score of HAMD-17, the duration of illness and admission times in MDD (P < 0.05 or 0.01). TEPS-CON was negatively related to PANSS total scores and negative symptoms (P < 0.05 or 0.01), but no significant correlation was found with duration of illness and admission times in schizophrenia (P > 0.05). There was no significant correlation between TEPS-ANT and any clinical variables (P > 0.05).

Conclusions

The consummatory and anticipatory pleasures were both impaired in MDD and schizophrenia. Consummatory and anticipatory anhedonia can be considered as a “state” in MDD, but as a “trait” in schizophrenia.
Literature
1.
American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders, 4th edn. American Psychiatric Association, Washington, DC
2.
Juckel G, Sass L, Heinz A (2003) Anhedonia, self-experience in schizophrenia, and implications for treatment. Pharmacopsychiatry 36:176–180CrossRef
3.
Loas G, Noisette C, Legrand A, Boyer P (2000) Is anhedonia a specific dimension in chronic schizophrenia? Schizophr Bull 26:495–506CrossRefPubMed
4.
Nagayamal H, Kubo S, Hatano T, Shinsuke H, Tetsuya M, Takafumi H, Taro K, Hiroo T, Masayuki Y, Nobuatsu N, Osamu K, Manabu I, Hideki S, Tatsuya T, Tsuyoshi U, Hirohisa W, Satoshi K (2012) Validity and reliability assessment of a Japanese version of the Snaith-Hamilton Pleasure Scale. Intern Med 51:865–869CrossRef
5.
Klein D (1984) Depression and anhedonia. In: Clark DC, Fawcett J (eds) Anhedonia and affect deficit states. PMA Publishing, New York, pp 1–14
6.
Hasler G, Drevets WC, Manji HK, Charney DS (2004) Discovering endophenotypes for major depression. Neuropsychopharmacol 29:1765–1781
7.
Joiner T, Brown J, Metalsky G (2003) A test of the tripartite model’s prediction of anhedonia’s specificity to depression: patients with major depression versus patients with schizophrenia. Psychiatry Res 119:243–250CrossRefPubMed
8.
9.
Pizzagalli DA, Iosifescu D, Hallett LA, Ratner KG, Fava M (2008) Reduced hedonic capacity in major depressive disorder: evidence from a probabilistic reward task. J Psychiatr Res 43:76–87PubMedCentralCrossRefPubMed
10.
Treadway MT, Buckholtz JW, Schwartzman AN, Lambert WE, Zald DH (2009) Worth the ‘EEfRT’? The effort expenditure for rewards task as an objective measure of motivation and anhedonia. PLoS One 4:e6598PubMedCentralCrossRefPubMed
11.
12.
13.
Blanchard JJ, Mueser KT, Bellack AS (1998) Anhedonia, positive and negative affect, and social functioning in schizophrenia. Schizophr Bull 24:413–424CrossRefPubMed
14.
Loas G, Boyer P, Legrand A (1999) Anhedonia and the deficit syndrome of schizophrenia. Psychopathology 32:207–219CrossRefPubMed
15.
16.
Silver H, Shlomo N (2012) Anhedonia and schizophrenia: how much is in the eye of the beholder? Compreh Psychiatry 43:65–68CrossRef
17.
Berenbaum H, Fujita F (1994) Schizophrenia and personality: Exploring the boundaries and connections between vulnerability and outcome. J Abnorm Psychol 103:148–158CrossRefPubMed
18.
19.
Cohen AS, Minor KS (2010) Emotional experience in patients with schizophrenia revisited: meta-analysis of laboratory studies. Schizophr Bull 36:143–150PubMedCentralCrossRefPubMed
20.
21.
Gard DE, Gard MG, Kring AM, John OP (2006) Anticipatory and consummatory components of the experience of pleasure: a scale development study. J Res In Personal 40:1086–1102CrossRef
22.
Gard DE, Kring AM, Gard MG, Horan WP, Green MF (2007) Anhedonia in schizophrenia:distinctions between anticipatory and consummatory pleasure. Schizophr Res 93:253–260PubMedCentralCrossRefPubMed
23.
Favrod J, Ernst F, Giuliani F, Bonsack C (2009) Validation of the temporal experience of pleasure scale (TEPS) in a French-speaking environment. Encephale 35:241–248CrossRefPubMed
24.
Chan RCK, Wang Y, Huang J, Shi Y, Wang Y, Hong X, Ma Z, Li Z, Lai MK, Kring AM (2010) Anticipatory and consummatory components of the experience of pleasure in schizophrenia: cross-cultural validation and extension. Psychiatry Res 175:181–183CrossRefPubMed
25.
Strauss GP, Wilbur RC, Warren KR, August SM, Gold JM (2011) Anticipatory vs. consummatory pleasure: What is the nature of hedonic deficitsin schizophrenia? Psychiatry Res 187:36–41PubMedCentralCrossRefPubMed
26.
Buck B, Lysaker PH (2013) Consummatory and anticipatory anhedonia in schizophrenia: stability, and associations with emotional distress and social function over six months. Psychiatry Res 205:30–35CrossRefPubMed
27.
Chan RCK, Shi Y, Lai M, Wang YN, Wang Y (2012) The temporal experience of pleasure scale (TEPS): exploration and confirmation of factor structure in a healthy chinese sample. PLoS ONE 7:e35352PubMedCentralCrossRefPubMed
28.
Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:561–571CrossRefPubMed
29.
Jerusalem M, Schwarzer R (1992) Self-efficacy as a resource factor in stress appraisal processes. Hemisphere, Washington DC
30.
Tang YH (2005) Hamilton Depression Scale. In: Zhang ZJ (ed) Behavioral medicine inventory manual. The Chinese Medicine Electronic Audio And Video Publishing House, Beijing, pp 224–227
31.
He YL (2005) Positive and Negative Syndrome Scale. In: Zhang ZJ (ed) Behavioral medicine inventory manual. The Chinese Medicine Electronic Audio And Video Publishing House, Beijing, pp 355–359
32.
Pizzagalli DA, Jahn AL, O’shea JP (2005) Toward an objective characterization of an anhedonia phenotype: a signal-detection approach. Biol Psychiatry 57:319–327PubMedCentralCrossRefPubMed
33.
Gershon AA, Vishne T, Grunhaus L (2007) Dopamine D2-like recepters and the antidepressant response. Biol Psych: Blunted response to feedback information in depressive illness. Brain 130:2367–2374CrossRef
34.
Steele JD, Kumar P, Ebmeier KP (2007) Blunted response to feedback information in depressive illness. Brain 130:2367–2374CrossRefPubMed
35.
Willner P, Hale AS, Argyropoulos S (2005) Dopaminergic mechanism of antidepressant action in depressed patients. J Affect Disord 86:37–45CrossRefPubMed
36.
37.
38.
Nestler EJ, Carlezon WA (2006) The mesolimbic dopamine reward circuit in depression. Biol Psychiatry 59:1151–1159CrossRefPubMed
39.
Barnes NM, Sharp T (1999) A review of central 5-HT receptors and their function. Neuropharmacology 38:1083–1152CrossRefPubMed
40.
Yan QS (2000) Activation of 5-HT2A/2C receptors within the nucleus accumbens increases local dopaminergic transmission. Brain Res Bull 51:75–81CrossRefPubMed
41.
Marutani T, Yahata N, Ikeda Y, Ito T, Yamamoto M, Matsuura M, Matsushima E, Okubo Y, Suzuki H, Matsuda T (2011) Functional magnetic resonance imaging study on the effects of acute single administration of paroxetine on motivation-related brain activity. Psychiatry Clin Neurosci 65:191–198CrossRefPubMed
42.
Awad AG, Voruganti LN (2005) Neuroleptic dysphoria: revisiting the concept 50 years later. Acta Psychiatr Scand 111(Suppl):6–13CrossRef
43.
Berridge KC, Robinson TE (1998) What is the role of dopamine in reward: Hedonic impact, reward learning, or incentive salience? Brain Res Rev 28:309–369CrossRefPubMed
44.
Berrridge KC (2007) The debate over dopamine’s role in reward: The case for incentive salience. Psychopharmacol 191:391–431CrossRef
45.
46.
47.
Juckel G, Schlagenhauf F, Koslowski M, Wustenberg T, Villringer A, Knutson B, Kienast T, Gallinat J, Wrase J, Heinz A (2006) Dysfunction of ventral striatal reward prediction in schizophrenia. Neuroimage 29:409–416CrossRefPubMed
48.
Mathews JR, Barch DM (2006) Episodic memory for emotional and non-emotional words in individuals with anhedonia. Psychiatry Res 143:121–133CrossRefPubMed
49.
Chentsova-Dutton Y, Hanley K (2010) The effects of anhedonia and depression on hedonic responses. Psychiatry Res 179:176–180CrossRefPubMed
50.
Kaviani H, Gray J, Checkley S, Raven P, Wilson G, Kumari V (2004) Affective modulation of the startle response in depression: influence of the severity of depression, anhedonia, and anxiety. J Affect Disord 83:21–31CrossRefPubMed
51.
Leventhal AM, Chasson GS, Tapia E, Miller E, Pettit JW (2006) Measuring hedonic capacity in depression: a psychometric analysis of three anhedonia scales. J Clin Psychol 62:1545–1558CrossRefPubMed
52.
Vollmayr B, Henn FA (2003) Stress models of depression. Clin Neurosci Res 3:245–251CrossRef
53.
Fawcett J, Clark D, Scheftner A (1982) Differences between anhedoniaand normal hedonic depressive states. Am J Psychiatry 140:1027–1030
54.
Silver H, Shlomo N (2002) Anhedonia and schizophrenia: how much is in the eye of the beholder? Compreh Psychiatry 43:65–68CrossRef
55.
Rey ER, Bailer J, Brauer W, Händel M, Laubenstein D, Stein A (1994) Stability trends and longitudinal correlations of negative and positive syndromes within a three-year follow-up of initially hospitalized schizophrenics. Acta Psychiat Scand 90:405–412CrossRefPubMed
56.
Herbener ES, Harrow M (2002) The course of anhedonia during 10 years of schizophrenic illness. J Abnorm Psychol 111:237–248CrossRefPubMed
57.
Kontaxakis VP, Kollias CT, Havaki-Kontaxaki BJ, Margariti MM, Stamouli SS, Petridou E, Christodoulou GN (2006) Physical anhedonia in the acute phase of schizophrenia. Ann Gen Psychiatry 5:1PubMedCentralCrossRefPubMed
58.
Brebion G, David AS, Jones H, Pilowsky LS (2005) Hallucinations, negative symptoms, and response bias in a verbal recognition task in schizophrenia. Neuropsychol 19:612–617CrossRef
59.
Huxley A, Fonseca AS (2014) The relationship between anhedonia and positive, negative, and general symptomatology in patients with schizophrenia. Ment Health Nurs 35:122–126CrossRef
Metadata
Title
A comparative study of anhedonia components between major depression and schizophrenia in Chinese populations
Authors
Yinghui Li
Xiaodong Mou
Wenhao Jiang
Zhong Yang
Xinhua Shen
Zhuma Jin
Zhiping Dai
Yuju Liu
Shengqin Mao
Jian Zhang
Yonggui Yuan
Publication date
01-12-2015
Publisher
BioMed Central
Published in
Annals of General Psychiatry / Issue 1/2015
Electronic ISSN: 1744-859X
DOI
https://doi.org/10.1186/s12991-015-0061-3

Other articles of this Issue 1/2015

Annals of General Psychiatry 1/2015 Go to the issue

Primary research

Anxiety and depression among Greek men with primary erectile dysfunction and premature ejaculation

Primary research

Prognostic influence of witness/victim experiences and PTSD-specific symptoms on working and educational capacity: a comparison between two groups of individuals post-trauma

Review

Clinical and economic outcomes of adjunctive therapy with pregabalin or usual care in generalized anxiety disorder patients with partial response to selective serotonin reuptake inhibitors

Primary research

Sex differences in plasma clozapine and norclozapine concentrations in clinical practice and in relation to body mass index and plasma glucose concentrations: a retrospective survey

Review

The role of cognitive dysfunction in the symptoms and remission from depression

Primary research

Outcome of cognitive performances in bipolar euthymic patients after a depressive episode: a longitudinal naturalistic study